Results 101 to 110 of about 1,097,723 (197)

Tyrosine Kinases in Cancer.

Biomarker insights, 2015
Blau, Olga, Afanasyev, Boris, Blau, Igor Wolfgang   +2 more
openaire   +2 more sources

Recent Progress in Urea-Containing Compounds as Tyrosine Kinase Inhibitors. [PDF]

Chem Biodivers
Sroor FM.
europepmc   +1 more source

Exploring the potential of vamotinib in Ph+ leukemias: is it indeed a 3rd generation tyrosine kinase-inhibitor? [PDF]

J Hematol Oncol
Lucini C, Sponseiler I, Bandian AM, Senkiv J, Lion T.   +4 more
europepmc   +1 more source

Spleen Tyrosine Kinase in Malignancies and Sepsis: Pathophysiological Roles and Biomarker Potential-A Narrative Review. [PDF]

Biomolecules
Țocu G, Ștefănescu BI, Pleșea Condratovici A, Luțenco V, Stavăr Matei L, Țocu L, Mihailov R, Mihailov OM, Dragostin OM, Tutunaru D, Pelin AM, Hangan LT, Chirilă SI, Cort A, Mehedinți MC, Mocanu E.   +15 more
europepmc   +1 more source

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis. [PDF]

Drugs
Lambe J, Fox RJ.
europepmc   +1 more source

Neuron myelination is accelerated by Bruton's tyrosine kinase inhibition via microglial extracellular vesicles. [PDF]

Front Cell Neurosci
Tartaglia M, Ioni A, De Luca M, Vilardo L, D'Agnano I, Conte A, Limatola C, Catalano M.   +7 more
europepmc   +1 more source

Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review. [PDF]

Front Med (Lausanne)
Fu AZ, Mowforth OD, Chintapalli R, Brown S, Hardyman F, Mair R.   +5 more
europepmc   +1 more source

Insulin receptor tyrosine kinase (INSR tyrosine kinase) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Phytochemicals Modulating Receptor Tyrosine Kinase Signaling Networks in Endometriosis. [PDF]

Pharmaceuticals (Basel)
Hsu CF, Weng CF.
europepmc   +1 more source

Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk. [PDF]

Neurotherapeutics
Malaty GR, Killion JA, Doddamreddy SA, Laurido-Soto OJ, Racette BA.   +4 more
europepmc   +1 more source